TY - JOUR AU - Guerrouahen, Bella AU - Martín Molina, Francisco PY - 2021 UR - http://hdl.handle.net/10481/67025 AB - The progress in the isolation and characterization of tumor antigen (TA)-specific T lymphocytes and in the genetic modification of immune cells allowed the clinical development of adoptive cell therapy (ACT). Several clinical studies highlighted... LA - eng PB - FRONTIERS MEDIA SA KW - Cancer KW - Immunotherapy KW - CAR-T cells KW - TCR engineered lymphocytes KW - CAR-NK cells KW - Monoclonal antibody KW - Clinical trials KW - Off-the-shelf development TI - Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar DO - 10.3389/fimmu.2020.589381 ER -